123
Participants
Start Date
June 4, 2020
Primary Completion Date
November 23, 2022
Study Completion Date
November 23, 2022
Spesolimab
Solution for injection
Placebo
Solution for injection
Chang Gung Medical Foundation (CGMF) - Linkou Bran, Linkou District
La Rabta Hospital, Tunis
Charles Nicolle Hospital, Tunis
Habib Thameur Hospital, Tunis
Hedi Chaker Hospital, Department of Dermatology, Sfax
Brussels - UNIV Saint-Luc, Brussels
Center for Skin Research, Testing and Product Development, Makati City
Farhat Hached Hospital, Sousse
Iloilo Doctors Hospital, Iloilo City, Iloilo
Arthritis Clinical Research Trials, Cape Town
Southern Philippines Medical Center, Davao City
National Hospital of Dermatology and Venereology, Hà Nội
National Taiwan University Hospital, Taipei
King Chulalongkorn Memorial Hospital, Bangkok
Institute of Dermatology, Bangkok
Ramathibodi Hospital, Ratchatewi, Bangkok
Hospital Pulau Pinang, Pulau Pinang
Uludag University Medicine Faculty Departmant of Dermatology, Bursa
Istituto Clinico Humanitas, Rozzano (MI)
Klinikum Oldenburg AöR, Oldenburg
Hospital Universitario 12 de Octubre, Madrid
Hospital Raja Permaisuri Bainun, Ipoh
Bezmi Alem Valide Sultan Vakif Gureba Egitim ve Arastirma Hastanesi, Istanbul
Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul
Marmara Universitesi Tip Fakultesi, Istanbul
Centro de Investigación de Enfermedades Autoinmunes S.C., Guadalajara
Universitätsklinikum Münster, Münster
Oakland Hills Dermatology, Auburn Hills
Fachklinik Bad Bentheim, Bad Bentheim
Pusan National Univ. Hosp, Busan
Hospital Kuala Lumpur, Kuala Lumpur
Universitätsklinikum Bonn AöR, Bonn
"General Hospital of Thessaloniki Ippokrateio", Thessaloniki
Universitätsklinikum Frankfurt, Frankfurt am Main
Washington University School of Medicine, St Louis
Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey
HCMC Hospital of Dermato-Venereology, Ho Chi Minh City
HOP Saint-Louis, Paris
Hospital Sultanah Aminah, Johor Bahru
Klinikum der Universität München - Campus Innenstadt, München
Hospital Sultan Ismail, Johor Bahru
Hospital Pakar Sultanah Fatimah, Muar town
Queen Elizabeth Hospital, Kota Kinabalu
Sarawak General Hospital, Kuching, Sarawak
Universitätsklinikum Würzburg AÖR, Würzburg
The First Hospital of China Medical University, Shenyang
LLC Skin Disease Clinic of Pier Volkenstein, St. Petersburg, Saint Petersburg
"LLC Avrora Medfort", Saint Petersburg
1stPavlov St.Med.Univ.St.-Petersburg Res.Inst., Saint Petersburg
Shanghai Skin Disease Hospital, Shanghai
Huashan Hospital, Fudan University, Shanghai
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
Saratov State Med.Univ.n.a.Razumovskogo, Saratov
"LLC Medical Center Azbuka Zdorovia", Kazan'
SBHI Chelyabinsk Reg.Clin.Derma.Dispen., Chelyabinsk
Sun yet-sen Memorial Hospital, Sun yet-sen Univesity, Guangzhou
"FSBEI HE Kirov State Medical University", Kirov
Second Affiliated Hospital of Xi'an JiaoTong University, Xi'an
Clínica Dermacross S.A., Vitacura
Buenos Aires Skin S.A., CABA
Hospital Italiano de Buenos Aires, CABA
HOP l'Archet, Nice
Nagoya City University Hospital, Aichi, Nagoya
Kyushu Rosai Hospital, Fukuoka, Kitakyushu
Tokyo Medical University Ibaraki Medical Center, Ibaraki, Inashiki-gun
Saitama Medical University Hospital, Saitama, Iruma-gun
Tokyo Medical University Hachioji Medical Center, Tokyo, Hachioji
Tokyo Medical University Hospital, Tokyo, Shinjuku-ku
Erasmus Medisch Centrum, Rotterdam
Severance Hospital, Seoul
Hospital Sant Joan de Déu, Esplugues Del Llobregat
Lead Sponsor
Boehringer Ingelheim
INDUSTRY